Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Research

Translation and validation of a simplified Chinese version of the psychosocial assessment tool

Authors: Jun Kou, Ruiqi Wang, Yuxin Tang, Yi Tang, Yang Gao

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Background

The Psychosocial Assessment Tool (PAT2.0) is widely used to assess psychosocial risk in families of children with cancer. Our study aims to apply PAT2.0 to Chinese patients and assess the reliability, content validity, and construct validity of the Chinese version.

Methods

A total of 161 participants completed the study, each with only one child diagnosed with cancer. Psychometric evaluations, including internal consistency, score distribution, test-retest reliability, and construct validity, were conducted.

Results

Cronbach’s alpha values ranged from 0.732 to 0.843, indicating good internal consistency. Additionally, intraclass correlation coefficient values ranged from 0.869 to 0.984, indicating excellent test-retest reliability. The Simplified Chinese version of PAT2.0 demonstrated high construct validity in factor analyses and correlations with the General Functioning Subscale of the Family Assessment Device.

Conclusion

The translation process of the Chinese version of PAT2.0 was successful, proving its applicability for psychosocial evaluation and interventions in families of children with cancer in China.
Literature
1.
Spector LG, Pankratz N, Marcotte EL. Genetic and nongenetic risk factors for childhood cancer. Pediatr Clin North Am. 2015;62(1):11–25.CrossRefPubMed
2.
Kazak AE, Noll RB. The integration of psychology in pediatric oncology research and practice: collaboration to improve care and outcomes for children and families. Am Psychol. 2015;70(2):146–58.CrossRefPubMed
3.
Liu Y, Sundquist J, Sundquist K, Zheng D, Ji J. Mental health outcomes in parents of children with a cancer diagnosis in Sweden: a nationwide cohort study. EClinicalMedicine. 2022;55:101734.CrossRefPubMedPubMedCentral
4.
Gout AM, Arunachalam S, Finkelstein DB, Zhang J. Data-driven approaches to advance research and clinical care for pediatric cancer. Biochim Biophys Acta Rev Cancer. 2021;1876(1):188571.CrossRef
5.
Ni X, Li Z, Li X, et al. Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China: a cross-sectional study. Lancet. 2022;400(10357):1020–32.CrossRef
6.
Pai AL, Patiño-Fernández AM, McSherry M, et al. The psychosocial assessment tool (PAT2.0): psychometric properties of a screener for psychosocial distress in families of children newly diagnosed with cancer. J Pediatr Psychol. 2008;33(1):50–62.CrossRef
7.
KSP, Wendy M, Anne T et al. Distress screening, rater agreement, and services in pediatric oncology. Psycho-oncology. 2011;20(12):1324–33.
8.
EAK, Stephanie S, Stephen D et al. Family psychosocial risk screening guided by the pediatric psychosocial preventative health model (PPPHM) using the psychosocial assessment tool (PAT). Acta oncologica (Stockholm, Sweden). 2015;54(5):574–80.
9.
Sint Nicolaas SM, Schepers SA, Hoogerbrugge PM, et al. Screening for psychosocial risk in Dutch families of a child with cancer: reliability, validity, and usability of the psychosocial assessment tool. J Pediatr Psychol. 2016;41(7):810–9.CrossRef
10.
Tsumura A, Okuyama T, Ito Y, et al. Reliability and validity of a Japanese version of the psychosocial assessment tool for families of children with cancer. Jpn J Clin Oncol. 2020;50(3):296–302.CrossRef
11.
Kalip K, Odabaş D. Turkish validity and reliability study of psychosocial assessment tool oncology version. Turk Arch Pediatr. 2023;58(1):20–7.CrossRef
12.
Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417–32.CrossRef
13.
Kou J, Xu W, Sun Q, Xie Q, Wang W. Translation and validation of the simplified Chinese version of the chronic pain coping inventory-42. J Orthop Surg Res. 2023;18(1):451. Published 2023 Jun 24.CrossRef
14.
Jun K, Bing D, Jinbiao L et al. Translation and validation of a simplified Chinese version of the anterior cruciate ligament-quality of life questionnaire. Orthop J Sports Med. 2023;11(6):23259671231175935–5.
15.
Epstein NB, Baldwin LM, Bishop DS. THE McMaster family assessment device. J Marital Family Therapy. 1983;9(2):171–80.CrossRef
16.
Johnson EG, Davis EB, Johnson J, Pressley JD, Sawyer S, Spinazzola J. The effectiveness of trauma-informed wilderness therapy with adolescents: a pilot study. Psychol Trauma. 2020;12(8):878–87.CrossRefPubMed
17.
Li R, Xu F, Ji L. Revision of family assessment device(FAD). China J Health Psychol. 2013;21(07):996–1000.
18.
Li DH, Wang W, Li X, et al. Development of a valid simplified Chinese version of the international hip outcome tool (SC-iHOT-33) in young patients having total hip arthroplasty. Osteoarthritis Cartilage. 2017;25(1):94–8.CrossRef
19.
Wang W, Xie QY, Jia ZY, et al. Cross-cultural translation of the western Ontario cuff index in Chinese and its validation in patients with rotator cuff disorders. BMC Musculoskelet Disord. 2017;18(1):178.CrossRef
20.
Terwee BC, Bot DS, Boer DRM, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2006;60(1):34–42.
21.
Cao S, Cao J, Li S, Wang W, Qian Q, Ding Y. Cross-cultural adaptation and validation of the simplified Chinese version of Copenhagen hip and groin outcome score (HAGOS) for total hip arthroplasty. J Orthop Surg Res. 2018;13(1):278.CrossRef
22.
Wang W, Liao D, Kang X, et al. Development of a valid Chinese version of the Cumberland ankle instability tool in Chinese-speaking patients with chronic ankle instability disorders. Sci Rep. 2021;11(1):9747.CrossRefADS
23.
GWH. Measures of reliability in sports medicine and science. Sports medicine (Auckland, N.Z.). 2000;30(1):1–15.
24.
SJF. Computing measures of simplicity of fit for loadings in factor-analytically derived scales. Behavior research methods, instruments, computers. J Psychonomic Soc Inc. 2003;35(4):520–4.
25.
Ye G, Hongliang D, Guizhi J et al. Translation of the Chinese version of the nomophobia questionnaire and its validation among college students: factor analysis. JMIR mHealth and uHealth. 2020;8(3):e13561.
26.
Jia ZY, Cui J, Wang W, et al. Translation and validation of the simplified Chinese version of the anterior cruciate ligament-return to sport after injury (ACL-RSI). Knee Surg Sports Traumatol Arthrosc. 2018;26(10):2997–3003.CrossRef
Metadata
Title
Translation and validation of a simplified Chinese version of the psychosocial assessment tool
Authors
Jun Kou
Ruiqi Wang
Yuxin Tang
Yi Tang
Yang Gao
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-11947-x

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue

Research

Does transanal drainage tubes placement have an impact on the incidence of anastomotic leakage after rectal cancer surgery? a systematic review and meta-analysis

Research

The associates of anxiety among lung cancer patients: Dehydroepiandrosterone (DHEA) as a potential biomarker

Research

Anticipated time to seek medical advice for possible lung cancer symptoms and barriers to timely presentation in Palestine: a national cross-sectional study

Research

Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients

Research

A cost-benefit analysis of genetic screening test for breast cancer in Iran

Research

EMP3 as a prognostic biomarker correlates with EMT in GBM
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits